Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)
Clinical trial NCT00236041 · COMPLETED
Trial details
- NCT number
- NCT00236041
- Sponsor
- Cephalon
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-04-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.